BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23564231)

  • 1. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness.
    Rao A; Sorkin A; Zahniser NR
    Synapse; 2013 Oct; 67(10):668-77. PubMed ID: 23564231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.
    Ragu Varman D; Subler MA; Windle JJ; Jayanthi LD; Ramamoorthy S
    Behav Brain Res; 2021 Jun; 408():113267. PubMed ID: 33794225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.
    Mandt BH; Zahniser NR
    Neuropharmacology; 2010 Mar; 58(3):605-12. PubMed ID: 19951714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
    Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
    J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.
    Jensen KL; Sørensen G; Dencker D; Owens WA; Rahbek-Clemmensen T; Brett Lever M; Runegaard AH; Riis Christensen N; Weikop P; Wörtwein G; Fink-Jensen A; Madsen KL; Daws L; Gether U; Rickhag M
    eNeuro; 2018; 5(3):. PubMed ID: 29911172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter inhibition and 5-HT
    Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
    Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
    O'Neill B; Tilley MR; Han DD; Thirtamara-Rajamani K; Hill ER; Bishop GA; Zhou FM; During MJ; Gu HH
    Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen Directly Interacts with the Dopamine Transporter.
    Mikelman SR; Guptaroy B; Schmitt KC; Jones KT; Zhen J; Reith MEA; Gnegy ME
    J Pharmacol Exp Ther; 2018 Oct; 367(1):119-128. PubMed ID: 30108161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.
    Aggarwal S; Liu X; Rice C; Menell P; Clark PJ; Paparoidamis N; Xiao YC; Salvino JM; Fontana ACK; España RA; Kortagere S; Mortensen OV
    ACS Chem Neurosci; 2019 Aug; 10(8):3718-3730. PubMed ID: 31184115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression.
    Tilley MR; Cagniard B; Zhuang X; Han DD; Tiao N; Gu HH
    BMC Neurosci; 2007 Jun; 8():42. PubMed ID: 17584943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J; Mactutus CF; Wallace DR; Booze RM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number.
    Nelson AM; Larson GA; Zahniser NR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):985-97. PubMed ID: 19729579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent.
    Mayfield RD; Zahniser NR
    Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
    Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
    J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.